Joy C. Yang

6.1k total citations · 2 hit papers
75 papers, 4.8k citations indexed

About

Joy C. Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joy C. Yang has authored 75 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 42 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Joy C. Yang's work include Prostate Cancer Treatment and Research (41 papers), Cancer, Lipids, and Metabolism (10 papers) and Ubiquitin and proteasome pathways (8 papers). Joy C. Yang is often cited by papers focused on Prostate Cancer Treatment and Research (41 papers), Cancer, Lipids, and Metabolism (10 papers) and Ubiquitin and proteasome pathways (8 papers). Joy C. Yang collaborates with scholars based in United States, China and Taiwan. Joy C. Yang's co-authors include Christopher P. Evans, Allen C. Gao, Gino Cortopassi, Thenappan Chandrasekar, Hsing-Jien Kung, Wei Lou, Chengfei Liu, Ralph W. deVere White, Nagalakshmi Nadiminty and Michael G. Rosenfeld and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Joy C. Yang

75 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs

2013 520 citations Joy C. Yang, Christopher P. Evans et al. profile →
Mechanisms of resistance in castration-resistant prostate cancer (CRPC).

2015 424 citations Thenappan Chandrasekar, Joy C. Yang et al. PubMed Central profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joy C. Yang United States	35	3.0k	1.8k	1.7k	736	457	75	4.8k
Adrie van Bokhoven United States	35	2.5k 0.8×	1.1k 0.6×	1.6k 0.9×	992 1.3×	275 0.6×	74	4.6k
Natasha Kyprianou United States	37	2.7k 0.9×	981 0.5×	1.8k 1.0×	1.3k 1.7×	227 0.5×	106	5.0k
Masaki Shiota Japan	39	2.3k 0.8×	1.1k 0.6×	2.0k 1.2×	945 1.3×	152 0.3×	253	4.3k
Lisa M. Butler Australia	41	4.0k 1.4×	2.1k 1.2×	1.8k 1.0×	1.6k 2.2×	199 0.4×	149	6.7k
Claudio Festuccia Italy	45	2.8k 1.0×	1.1k 0.6×	1.1k 0.7×	1.6k 2.2×	274 0.6×	164	5.3k
Paloma Cejas Spain	27	2.9k 1.0×	1.3k 0.7×	832 0.5×	1.3k 1.7×	214 0.5×	72	4.5k
Sunmin Lee United States	30	2.7k 0.9×	1.3k 0.7×	741 0.4×	724 1.0×	204 0.4×	63	4.3k
Philippe Bougnoux France	46	2.5k 0.8×	2.0k 1.1×	600 0.4×	1.7k 2.3×	260 0.6×	182	6.7k
Natasha Kyprianou United States	49	3.9k 1.3×	1.7k 0.9×	2.7k 1.6×	2.0k 2.7×	245 0.5×	135	7.5k
Cullen M. Taniguchi United States	25	2.8k 0.9×	962 0.5×	577 0.3×	939 1.3×	1.2k 2.5×	128	5.9k

Countries citing papers authored by Joy C. Yang

Since Specialization

Citations

This map shows the geographic impact of Joy C. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy C. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy C. Yang more than expected).

Fields of papers citing papers by Joy C. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy C. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy C. Yang. The network helps show where Joy C. Yang may publish in the future.

Co-authorship network of co-authors of Joy C. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Joy C. Yang. A scholar is included among the top collaborators of Joy C. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy C. Yang. Joy C. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jianhua, Anthony Carlo, Woodrow Burchett, et al.. (2024). Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes. The AAPS Journal. 26(3). 36–36. 3 indexed citations

Chen, Bo, Pengfei Xu, Joy C. Yang, et al.. (2024). Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene. 43(30). 2325–2337. 3 indexed citations

Xu, Pengfei, Joy C. Yang, Bo Chen, et al.. (2023). Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer. 11(5). e006581–e006581. 24 indexed citations

Ning, Shu, Chengfei Liu, Wei Lou, et al.. (2022). Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Molecular Cancer Therapeutics. 21(10). 1594–1607. 16 indexed citations

Armstrong, Cameron M., Chengfei Liu, Liangren Liu, et al.. (2020). Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer. Clinical Cancer Research. 26(22). 6064–6074. 17 indexed citations

Liu, Chengfei, Joy C. Yang, Cameron M. Armstrong, et al.. (2019). AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer. Molecular Cancer Therapeutics. 18(10). 1875–1886. 53 indexed citations

Cucchiara, Vito, Joy C. Yang, Chengfei Liu, et al.. (2019). GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression. Molecular Cancer Therapeutics. 18(10). 1811–1821. 10 indexed citations

Nguyen, Hao G., Crystal S. Conn, Lingru Xue, et al.. (2018). Development of a stress response therapy targeting aggressive prostate cancer. Science Translational Medicine. 10(439). 115 indexed citations

Liu, Chengfei, Cameron M. Armstrong, Wei Lou, et al.. (2017). Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 16(8). 1521–1530. 54 indexed citations

10.

Shi, Xu-Bao, Ai-Hong Ma, Lingru Xue, et al.. (2015). miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. Cancer Research. 75(24). 5309–5317. 61 indexed citations

11.

Chandrasekar, Thenappan, Joy C. Yang, Allen C. Gao, & Christopher P. Evans. (2015). Mechanisms of resistance in castration-resistant prostate cancer (CRPC).. PubMed Central. 4(3). 365–80. 424 indexed citations breakdown →

12.

Nguyen, Hao G., Joy C. Yang, Derya Tilki, et al.. (2014). Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 33(36). 4521–4530. 179 indexed citations

13.

Nadiminty, Nagalakshmi, Ramakumar Tummala, Chengfei Liu, et al.. (2013). NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants. Molecular Cancer Therapeutics. 12(8). 1629–1637. 156 indexed citations

14.

Ganti, Sheila, Sandra L. Taylor, Omran Abu Aboud, et al.. (2012). Kidney Tumor Biomarkers Revealed by Simultaneous Multiple Matrix Metabolomics Analysis. Cancer Research. 72(14). 3471–3479. 100 indexed citations

15.

Guerrero, Erick G., Michael Campos, Darren Urada, & Joy C. Yang. (2012). Do cultural and linguistic competence matter in Latinos’ completion of mandated substance abuse treatment?. Substance Abuse Treatment Prevention and Policy. 7(1). 34–34. 39 indexed citations

16.

Bai, Lanfang, et al.. (2011). Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration. International Journal of Cancer. 130(11). 2693–2702. 28 indexed citations

17.

Wu, Zuoqiao, Pei‐Ching Chang, Joy C. Yang, et al.. (2010). Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors. Genes & Cancer. 1(1). 40–49. 137 indexed citations

18.

Yang, Joy C., et al.. (2008). Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer. Cancer Research. 69(1). 151–160. 57 indexed citations

19.

Shi, Xu-Bao, Lingru Xue, Joy C. Yang, et al.. (2007). An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proceedings of the National Academy of Sciences. 104(50). 19983–19988. 390 indexed citations

20.

Bai, Lanfang, et al.. (2006). Survey of Src activity and Src-related growth and migration in prostate cancer lines. Cancer Research. 66. 592–592. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact